http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Foundation Medicine And Mirati Therapeutics Collaborate To Develop A Companion Diagnostic For Glesatinib (MGCD265) In Non-Small Cell Lung Cancer (NSCLC)
-
Foundation Medicine Announces National Agreement with UnitedHealthcare for FoundationOne® in Metastatic Non-Small Cell Lung Cancer
-
Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium
-
AbbVie (ABBV) Announces Publication of Positive Venetoclax Data as CLL Treatment
-
Foundation Medicine to Present at the Goldman Sachs SMID Cap Growth Conference
-
Foundation Medicine and Collaborators to Present New Clinical Data Supporting Comprehensive Genomic Profiling in Advanced Sarcomas and Hematologic Malignancies with FoundationOne® Heme
-
Genentech to Present New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2015 Annual Meeting
-
Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights
-
Foundation Medicine Announces Roche Pharmaceuticals (Israel) Ltd. to Commence Commercial Activities in Support of its Molecular Information Products in Oncology
-
Foundation Medicine Announces Timing for Third Quarter 2015 Financial Results and Conference Call
-
Genentech’s Ocrelizumab First Investigational Medicine to Show Positive Pivotal Study Results in Both Relapsing and Primary Progressive Forms of Multiple Sclerosis
-
Foundation Medicine Launches Precision Medicine Exchange Consortium™ (PMEC) to Advance the Integration of Molecular Information in Clinical Oncology and Accelerate Adoption of Precision Care
-
Foundation Medicine Expands Molecular Information Decision Support Offerings with GeneKit™, a Genomic Solutions Portal for Pathologists
-
Foundation Medicine to Present at Morgan Stanley Global Healthcare Conference
-
Genentech (RHHBY) to Present at ECC
-
Genentech to Present Data from 15 Medicines Across Its Portfolio of Cancer Immunotherapy and Targeted Medicines During the 2015 European Cancer Congress
-
Foundation Medicine to Webcast Investor & Analyst Day
-
Wedbush Securities to Host Its Annual PacGrow Healthcare Management Access Conference in August 2015
-
Foundation Medicine to Present at Wedbush PacGrow Healthcare Conference
-
Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights
-
Foundation Medicine Initiates Multi-Center Clinical Study Evaluating Its Circulating Tumor DNA (ctDNA) Assay in Multiple Tumor Types
-
University of Colorado Cancer Center and Loxo Oncology Announce Publication That Provides Clinical Validation For LOXO-101 Against TRK Fusion Cancer
-
Foundation Medicine Announces Timing for Second Quarter 2015 Financial Results and Conference Call
-
Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO
-
Debiopharm International SA announces results of 2 key oncology programs at 2015 AACR Conference
-
Market Wrap: FOMC Split on QE Exit; Brace for More Hedge Fund Ads; GM is Big in China
-
Highlights From AAPL's Q4 Conference Call: Set New All-Time Records for Mac, iPhone and iPad Sales

